Top compounds associated with response to DNLZ


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.4
mRNA lovastatin CTRPv2 pan-cancer AAC 0.033 0.4
mRNA ML312 CTRPv2 pan-cancer AAC 0.069 0.4
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA PI-103 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.029 0.4
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.4
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.4
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.028 0.4
Download CSV